Without commercial interruption please read this important blog from Drug Channels about how insurers and PBMs are rigging drug prices to maximize profits and discourage access.
Insurance is -- to paraphrase the song Me and Bobby McGee -- has become another word for nothing left to lose, especially if you are one of the 4-5 percent of patients fighting cancer, automimmune diseases and orphan conditions. As Adam points out, the system is rigged against a minority of people. That's discrimination.
There is plenty of revenue from PBMSs, insurers and pharma that could be used to eliminate out of pocket spending on drugs. that mean drug companies can charge whatever they want, as critics claim? Hardly. Rather it means that drug spending will have to be part of a solution that are offered to consumers based on what they value. New medicines do not drive up health care costs long term, rather they make staying healthy more affordable and convenient. Every economic analysis shows that.
Instead of finger pointing about who is to blame, it's time to ramp up the shift to figuring out what value-based purchasing is and making it work. And it's time to find more ways to reduce the cost, time and uncertainty of drug development. Both challenges can be overcome by applying precision health tools to improve population well-being and leveraging new medicines to deliver even more value directly to people.